Vinge has advised XVIVO Perfusion AB in connection with a directed new issue of shares to Swedish and international investors that contributed MSEK 250 to XVIVO.
Vinge has advised Smart Eye Aktiebolag in connection with a directed new issue of shares to Swedish and international investors that contributed MSEK 220 to Smart Eye.
Vinge has advised Biotage AB (publ), listed on Nasdaq Stockholm, in connection with its acquisition of ATDBio Limited based in Oxford and Southampton, UK, for a total purchase price of approx. 45 MGBP on a debt free and cash free basis (corresponding to approx. 534.4 MSEK) financed through a combination of a share issue of new ordinary Biotage shares, cash at hand and a revolving credit facility. The transaction closed in connection with the entering into of the share purchase agreement.
Vinge has advised Isofol Medical AB in connection with its listing on Nasdaq Stockholm, with the first day of trading on 21 October 2021. The prospectus was approved by the Swedish Financial Supervisory Authority on 18 October 2021. Isofol has a market value corresponding to approximately SEK 1.5 billion.
Vinge has advised Flat Capital AB (publ) (“Flat Capital” or the “Company”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 29 September 2021 and the first day of trading on Nasdaq First North Growth Market was 20 October 2021.
The first day of trading on Nasdaq Stockholm large cap was 15 October 2021. The offer price was SEK 75 per share, equivalent to a market value for the Byggfakta Group of approximately SEK 16.4 billion. The offer covers 64,483,197 shares together with an oversubscription option to a total value of approximately SEK 5.5 billion.
Vinge advises Haypp Group AB (publ) (“Haypp Group”) in connection with the listing on Nasdaq First North Growth Market. The prospectus was published on 4 October 2021 and the first day of trading on Nasdaq First North Growth Market was 13 October 2021. The offering price was SEK 66 per share, corresponding to a market value of Haypp Group of approximately SEK 1,9 billion.
Vinge has advised eEducation Albert AB (publ) (”Albert”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 21 September 2021 and the first day of trading occurred on 1 October 2021.
Vinge has advised CTEK AB (publ) (“CTEK” or the “Company”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 13 September 2021 and the first day of trading on Nasdaq Stockholm was 24 September 2021.
Vinge has advised Bactiguard Holding AB (publ) in connection with a directed share issue to AMF whereby the company raised proceeds of SEK 228 million.
